Rybin Vitalyi O, Guo Jianfen, Gertsberg Zoya, Elouardighi Hasnae, Steinberg Susan F
Department of Pharmacology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
J Biol Chem. 2007 Aug 10;282(32):23631-8. doi: 10.1074/jbc.M701676200. Epub 2007 Jun 14.
Protein kinase Cdelta (PKCdelta) is unusual among AGC kinases in that it does not require activation loop (Thr(505)) phosphorylation for catalytic competence. Nevertheless, Thr(505) phosphorylation has been implicated as a mechanism that influences PKCdelta activity. This study examines the controls of PKCdelta-Thr(505) phosphorylation in cardiomyocytes. We implicate phosphoinositide-dependent kinase-1 and PKCdelta autophosphorylation in the "priming" maturational PKCdelta-Thr(505) phosphorylation that accompanies de novo enzyme synthesis. In contrast, we show that PKCdelta-Thr(505) phosphorylation dynamically increases in cardiomyocytes treated with phorbol 12-myristate 13-acetate or the alpha(1)-adrenergic receptor agonist norepinephrine via a mechanism that requires novel PKC isoform activity and not phosphoinositide-dependent kinase-1. We used a PKCepsilon overexpression strategy as an initial approach to discriminate two possible novel PKC mechanisms, namely PKCdelta-Thr(505) autophosphorylation and PKCdelta-Thr(505) phosphorylation in trans by PKCepsilon. Our studies show that adenovirus-mediated PKCepsilon overexpression leads to an increase in PKCdelta-Thr(505) phosphorylation. However, this cannot be attributed to an effect of PKCepsilon to function as a direct PKCdelta-Thr(505) kinase, since the PKCepsilon-dependent increase in PKCdelta-Thr(505) phosphorylation is accompanied by (and dependent upon) increased PKCdelta phosphorylation at Tyr(311) and Tyr(332). Further studies implicate Src in this mechanism, showing that 1) PKCepsilon overexpression increases PKCdelta-Thr(505) phosphorylation in cardiomyocytes and Src(+) cells but not in SYF cells (that lack Src, Yes, and Fyn and exhibit a defect in PKCdelta-Tyr(311)/Tyr(332) phosphorylation), and 2) in vitro PKCdelta-Thr(505) autophosphorylation is augmented in assays performed with Src (which promotes PKCdelta-Tyr(311)/Tyr(332) phosphorylation). Collectively, these results identify a novel PKCdelta-Thr(505) autophosphorylation mechanism that is triggered by PKCepsilon overexpression and involves Src-dependent PKCdelta-Tyr(311)/Tyr(332) phosphorylation.
蛋白激酶Cδ(PKCδ)在AGC激酶中较为特殊,因为其催化活性并不需要激活环(苏氨酸505)磷酸化。然而,苏氨酸505磷酸化被认为是影响PKCδ活性的一种机制。本研究探讨了心肌细胞中PKCδ-苏氨酸505磷酸化的调控机制。我们发现磷脂酰肌醇依赖性激酶-1和PKCδ自身磷酸化参与了伴随新酶合成的“引发”成熟性PKCδ-苏氨酸505磷酸化过程。相比之下,我们发现用佛波醇12-肉豆蔻酸酯13-乙酸酯或α1-肾上腺素能受体激动剂去甲肾上腺素处理心肌细胞时,PKCδ-苏氨酸505磷酸化会通过一种需要新型PKC同工型活性而非磷脂酰肌醇依赖性激酶-1的机制动态增加。我们采用PKCε过表达策略作为初步方法来区分两种可能的新型PKC机制,即PKCδ-苏氨酸505自身磷酸化和PKCε对PKCδ-苏氨酸505的反式磷酸化。我们的研究表明,腺病毒介导的PKCε过表达会导致PKCδ-苏氨酸505磷酸化增加。然而,这不能归因于PKCε作为直接的PKCδ-苏氨酸505激酶发挥作用,因为PKCε依赖性的PKCδ-苏氨酸505磷酸化增加伴随着(且依赖于)酪氨酸311和酪氨酸332处PKCδ磷酸化的增加。进一步的研究表明Src参与了这一机制,具体表现为:1)PKCε过表达会增加心肌细胞和Src阳性细胞中PKCδ-苏氨酸505磷酸化,但在SYF细胞(缺乏Src、Yes和Fyn且在PKCδ-酪氨酸311/酪氨酸332磷酸化方面存在缺陷)中不会增加;2)在有Src(可促进PKCδ-酪氨酸311/酪氨酸332磷酸化)参与的实验中,体外PKCδ-苏氨酸505自身磷酸化增强。总的来说,这些结果确定了一种由PKCε过表达触发且涉及Src依赖性PKCδ-酪氨酸311/酪氨酸332磷酸化的新型PKCδ-苏氨酸505自身磷酸化机制。